Author

Kefei Zhou 1

1 Amgen Inc.

CLINICAL PHARMACOLOGY AND SAFETY OF AMG 181, A HUMAN ANTI-Α4Β7 ANTIBODY FOR TREATING INFLAMMATORY BOWEL DISEASES

Wei-Jian Pan, Barbara Sullivan, William Rees, Christine Evangelista, David Doherty, Peter Prince, Kai Reynhardt, Kefei Zhou, David Han, Jonathan Lee, Zhigang Yu, Dominic Borie

CLINICAL PHARMACOLOGY, SAFETY, AND EFFECTS OF ANTI-IL-23 ANTIBODY AMG 139

Wei-Jian Pan, William Rees, Jennifer Towne, John Gibbs, Alexander Colbert, Theresa Goletz, Kathryn Newhall, Kefei Zhou, Samantha Prokop, Amber Umble-Romero, Christina Krill, Ping-Cheng Yi, Nathan Standifer, Jonathan Lee, George Hodsman, Jason Lickliter, John Wishart, Sepehr Shakib, Catherine Reid, Joanne Marjason, Chris

Efficacy of velusetrag treatment in patients with idiopathic gastroparesis: Subgroup analysis of a phase 2b study

Thomas Abell, Braden Kuo, Tuba Esfandyari, Daniel M. Canafax, Raffaella Tacchi, Maria Grimaldi, Giuseppe Viscomi, Cecilia Renzulli, Kefei Zhou, Deanna Nguyen, Chris Barnes, Richard W McCallum

SAFETY, PHARMACOLOGY, AND EFFECT OF AMG 181, A HUMAN ANTI-Α4Β7 ANTIBODY, IN SUBJECTS WITH MILD TO MODERATE ULCERATIVE COLITIS

Wei-Jian Pan, Howard Schwartz, William Rees, Barbara Sullivan, Christine Evangelista, David Doherty, Peter Prince, Kai Reynhardt, Kefei Zhou, Anthony Treacy, Jonathan Lee, Zhigang Yu, Jane Andrews, Dominic Borie

Item 1 - 4 / 4
1